HOXD11 and cancer: To further explore the relationship between HOXD11 expression and prognosis, Kaplan-Meier survival analysis was performed and the results revealed that HOXD11 overexpression led to a poor 5-year cancer-specific survival (CSS) rate (p < 0.001) (Fig. 2A).